Antipsychotic medications were initially developed to treat schizophrenia, a mental health condition characterised by psychotic symptoms such as delusions and
Continue reading »
Critically ill patients supported by respirators in ICUs may develop weakness from drug treatment, not illness
At least 25 percent of critically ill patients who receive mechanical ventilation in intensive care units (ICUs) develop muscular weakness
Continue reading »
Doctor finds spider spinning webs in patient’s ear
The unnamed patient described his discomfort as being like something “beating a drum” in his ear. (iStock) A doctor found
Continue reading »
Structure of tau filaments in patients with Pick’s disease determined
A team of researchers with the MRC Laboratory of Molecular Biology in the U.K. and Indiana University School of Medicine
Continue reading »
Gum disease treatment may improve symptoms in cirrhosis patients
Routine oral care to treat gum disease (periodontitis) may play a role in reducing inflammation and toxins in the blood
Continue reading »
Can echocardiography improve care of patients with pulmonary embolism?
The use of echocardiography, which creates two-dimensional images of the heart, can help clinicians better predict outcomes for individuals with
Continue reading »
Two strategies for preventing diabetes in minority patients
(HealthDay)—Recognizing the barriers to care for minority patients with type 2 diabetes could reduce the incidence of type 2 diabetes
Continue reading »
New aid to help identify and manage patients with diabetes at increased risk of fracture
Fragility fractures are a serious yet neglected complication of both type 1 and type 2 diabetes, with increased risk of
Continue reading »
New HIV therapy reduces virus, boosts immunity in drug-resistant patients
In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV
Continue reading »
Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved Gut Microbiome of Patients with CDI
Oxford, UK, and Cambridge, MA, US, 3 August 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces the publication
Continue reading »